Omburtamab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | CD276 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
UNII | |
Chemical and physical data | |
Formula | C6418H9840N1698O2016S50 |
Molar mass | 144.6 g/mol |
Omburtamab (INN) is a monoclonal antibody designed for the treatment of cancer.[1][2]
This drug is being developed by Memorial Sloan Kettering Cancer Center.
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.